Abstract: A flexible bag (10) has an open top configured and arranged for receiving one or more feed tubes (32). The bag (10) preferably includes at least one attachment member (20) adapted and configured to be secured to a support member (47). A fixture (50), (60), (70), (80) is utilized to receive the bag (10).
Abstract: A wheel mounting and height adjustment mechanism for use with a power equipment unit/implement such as a lawn mower. In one embodiment, the mechanism may include a block defining a plurality of bores, each bore to selectively receive an axle of a wheel assembly. A plate member may be provided in or near the block. The plate member may include a plurality of elongate cutouts such that a separate cutout is selectively alignable with each of the plurality of bores. When the plate member is in a disengaged position such that a first portion of each cutout is aligned with its respective bore, each cutout permits the axle to fully enter its respective bore. However, when the plate member is moved to an engaged position, each cutout may engage the axle to capture the respective wheel assembly.
Abstract: The present invention provides isolated lantibiotics that inhibit Gram negative and Gram positive microbes. The lantibiotic includes an amino acid sequence, wherein the amino acid sequence of the compound and the amino acid sequence of SEQ ID NO:21 or SEQ ID NO:22 have at least 80% identity. The lantibiotics have the characteristic of inhibiting growth of a Gram negative microbe in conditions that do not damage the outer membrane of the Gram negative microbe. The present invention also provides methods for making and using the lantibiotics.
Abstract: A holder and system for mixing a volume of material within a closed container in a mixing machine. Holders and systems in accordance with embodiments of the present invention may permit mixing of fluids in containers that are otherwise ill-suited for conventional mixing machines. The holder may include a receptacle or bucket into which a first insert or adapter is placed to receive and hold one end of the closed container. A second insert may also be inserted into the bucket to receive and hold a second end of the closed container. The bucket may include a tapered inner sidewall surface and one or both adapters may include side surfaces that generally conform to the sidewall surface.
Abstract: A capacitor for an implantable medical device is presented. The capacitor includes an anode, a cathode, a separator therebetween, and an electrolyte over the anode, cathode, and separator. The electrolyte includes ingredients comprising acetic acid, ammonium acetate, phosphoric acid, and tetaethylene glycol dimethyl ether. The capacitor has an operating voltage ninety percent or greater of its formation voltage.
Type:
Grant
Filed:
June 30, 2006
Date of Patent:
May 31, 2011
Assignee:
Medtronic, Inc.
Inventors:
Mark E. Viste, John D. Norton, Joachim Hossick-Schott, Anthony W. Rorvick
Abstract: A tool for slitting an elongate sheath from about an elongate member that is disposed within a longitudinally extending lumen of the sheath includes a longitudinally extending tail portion projecting rearward of a slitting edge and a nose portion of the tool; a lower surface of the nose portion is disposed beneath the slitting edge for engaging a portion of the elongate member. The tail portion of the tool, approximately aligned with the sheath lumen when the lower surface engages the elongate member and a leading edge of the nose portion is within the sheath lumen, is sized to fit within the sheath lumen after the sheath is slit by the slitting edge. A passageway between the nose portion and the tail portion allows a proximal segment of the elongate member to bend away from the tail portion when the elongate member is engaged by the nose portion.
Abstract: Systems and methods are provided for use in correcting flicker of a display (e.g., an LCD display). For example, correction may employ the insertion of at least one transition data frame between display data frames for use in displaying a transition image by pixel elements of the display such that a user perceives display of a constant average luminance by the pixel elements.
Type:
Grant
Filed:
February 23, 2007
Date of Patent:
May 31, 2011
Assignee:
Lockheed Martin Corporation
Inventors:
Scott J Benjamin, Martin J. Andrusiak, Ralph A. Werner
Abstract: Electrospray methods and systems for coating of objects (e.g., medical devices such as a stent structure) with an open matrix coating. The open matrix coating is formed by electrospray using one or more nozzle structures each having at least an inner and outer opening. A first flow of a liquid spray composition is provided to the inner opening and a second flow of a liquid diluent composition is provided to the outer opening (e.g., the liquid diluent composition including at least one solvent, such as a composition having a dielectric constant equal to or greater than 10).
Type:
Grant
Filed:
January 31, 2007
Date of Patent:
May 31, 2011
Assignee:
Regents of the University of Minnesota
Inventors:
Robert A. Hoerr, John V. Carlson, Da-Ren Chen, David Y. H. Pui
Abstract: The present invention provides compositions including siderophore receptor polypeptides and porins from gram negative microbes, and preferably, lipopolysaccarhide at a concentration of no greater than about 10.0 endotoxin units per milliliter. The present invention also provides methods of making and methods of using such compositions, including inducing the production of antibody in an animal.
Abstract: The present invention provides compositions including siderophore receptor polypeptides from gram negative microbes, and preferably, lipopolysaccharide at a concentration of no greater than about 10.0 endotoxin units per milliliter. The present invention also provides methods of making and methods of using such compositions, including inducing the production of antibody in an animal.
Abstract: A road and repair system and/or method using one or more components including a plurality of magnetite concentrate particles, at least one acidic activator including phosphate anions, and a plurality of reactive aggregate particles including iron.
Type:
Grant
Filed:
October 31, 2008
Date of Patent:
May 10, 2011
Assignee:
Regents of the University of Minnesota
Inventors:
Donald R. Fosnacht, David W. Hendrickson, Richard Kiesel, Lawrence M. Zanko, Tamara R. Diedrich
Abstract: The present invention provides methods for producing a polymyxin from an isolated Paenibacillus amylolyticus, and methods for using the polymyxin, including methods for producing a recombinant polypeptide.
Type:
Grant
Filed:
July 21, 2008
Date of Patent:
May 3, 2011
Assignee:
University of Georgia Research Foundation, Inc.
Inventors:
Joy Doran-Peterson, Emily Decrescenzo-Henriksen
Abstract: The present invention provides coating compositions that include substantially non-irritating ethylenically unsaturated compounds and have one or more of the following properties: high performance, low VOC levels, substantially no formaldehyde content, and low irritation levels.
Abstract: The present disclosure describes pathogenic bacteria that have been modified to be deficient in NiFe hydrogenase activity; compositions comprising such modified bacteria, and the use of such bacteria to protect animals from pathogenic enteric bacterial infections.
Type:
Grant
Filed:
February 28, 2005
Date of Patent:
April 5, 2011
Assignee:
University of Georgia Research Foundation, Inc.
Abstract: An all-wheel steering system and vehicle, e.g., riding lawn mower, incorporating the same. The system may include a linkage system that operatively connects the vehicle wheels for simultaneous turning. The system, in one embodiment, includes a power steering unit having fixed or variable output for a given steering input. The system may further include a mechanism for reducing speed based upon mower steering angle.
Type:
Grant
Filed:
February 4, 2008
Date of Patent:
April 5, 2011
Assignee:
The Toro Company
Inventors:
David J. Scherbring, Jesse R. Gamble, Jackie R. Gust
Abstract: A human Kunitz-type inhibitor polypeptide with enhanced antifibrinolytic activity, methods of making, and methods of use. The novel polypeptide is structurally similar to the KD1 domain of human tissue factor pathway inhibitor-2 (TFPI-2). In another aspect, methods of treating a subject afflicted with cancer or a precancerous condition are described. Generally, the method includes administering to a subject in need of treatment an effective amount of a polypeptide. In some embodiments, the polypeptide comprises a KD1 domain of human TFPI-2. In some embodiments, the polypeptide comprises human TFPI-2, itself. In certain embodiments, the polypeptide is administered in an amount effective to induce apoptosis in tumor cells.
Abstract: The present invention provides methods for synthesis and therapeutic use of DNA and RNA oligonucleotides and analogs. RNA oligonucleotides are synthesized using a small, circular DNA template which lacks an RNA polymerase promoter sequence. The RNA synthesis is performed by combining a circular single-stranded oligonucleotide template with an effective RNA polymerase and at least two types of ribonucleotide triphosphate to form an RNA oligonucleotide multimer comprising multiple copies of the desired RNA oligonucleotide sequence. Preferably, the RNA oligonucleotide multimer is cleaved to produce RNA oligonucleotides having well-defined ends. Preferred RNA oligonucleotide multimers contain ribozymes capable of both cis (autolytic) and trans cleavage.
Abstract: Compositions and methods for controlling or eliminating isotope effects during fractionation of chemically equivalent but isotopically distinct compounds. Isotope coding agents contain heavy isotopes other than deuterium. The invention facilitates intelligent data acquisition. After sample fractionation, isotope abundance ratios are calculated using mass spectrometry, and analytes of interest are identified in real time.
Abstract: A continuous flow bioreactor system that includes a bioreactor, an optional post-bioreactor preparation chamber, a cell sorter, and an optional pre-bioreactor preparation chamber in a closed loop, useful for enriching a heterogeneous cell population growing in the bioreactor with an isolated subpopulation of cells.
Type:
Grant
Filed:
November 3, 2008
Date of Patent:
March 8, 2011
Assignee:
Regents of the University of Minnesota
Inventors:
Friedrich Srienc, Abdelqader Zamamiri, Nicholas R. Abu-Absi, James A. Kacmar
Abstract: The present invention provides isolated polynucleotides and isolated polypeptides. The polypeptides of the present invention have isoprenoid wax ester synthase activity or isoprenoid acyl CoA-synthetase activity. The present invention also includes methods of using the polynucleotides and polypeptides of the present invention. For instance, the methods include producing biodiesel and producing wax esters.
Type:
Grant
Filed:
August 27, 2008
Date of Patent:
March 1, 2011
Assignee:
Regents of the University of Minnesota
Inventors:
Claudia Schmidt-Dannert, Erik K. Holtzapple